本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cytek BioSciences

4.60
-0.0300-0.65%
成交量:55.26萬
成交額:254.74萬
市值:5.91億
市盈率:-8.83
高:4.75
開:4.69
低:4.52
收:4.63
52周最高:6.18
52周最低:2.37
股本:1.29億
流通股本:1.09億
量比:0.55
換手率:0.51%
股息:- -
股息率:- -
每股收益(TTM):-0.5209
每股收益(LYR):-0.5209
淨資產收益率:-18.05%
總資產收益率:-5.25%
市淨率:1.73
市盈率(LYR):-8.83

資料載入中...

2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

重要事件披露

8-K - Current report
2022/03/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/02

重要事件披露

8-K - Current report
2022/02/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

重要事件披露

8-K - Current report
2022/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/06

重要事件披露

8-K - Current report
2021/09/02

季度報告

Cytek Biosciences, Inc.
2021/07/29

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

重要事件披露

8-K - Current report
2021/07/27

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/20

SEC問詢函

CORRESP [Cover] - Correspondence